help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Milne, S. A.
Right arrow Articles by Jabbour, H. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milne, S. A.
Right arrow Articles by Jabbour, H. N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PROSTAGLANDIN F2ALPHA
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 4 1825-1832
Copyright © 2003 by The Endocrine Society

Prostaglandin (PG) F2{alpha} Receptor Expression and Signaling in Human Endometrium: Role of PGF2{alpha} in Epithelial Cell Proliferation

Stuart A. Milne and Henry N. Jabbour

Medical Research Council Human Reproductive Sciences Unit, Centre for Reproductive Biology, Edinburgh EH16 4SB, United Kingdom

Address all correspondence and requests for reprints to: Dr. Henry N. Jabbour, Medical Research Council Human Reproductive Sciences Unit, Centre for Reproductive Biology, The Chancellor’s Building, 49 Little France Crescent, Edinburgh EH16 4SB, United Kingdom. E-mail: h.jabbour{at}hrsu.mrc.ac.uk.

Prostaglandin (PG) F2{alpha}, a member of the prostanoid bioactive lipid family, is secreted by human endometrium throughout the menstrual cycle and is present in both menstrual fluid and medium of endometrial explants in culture. PGF2{alpha} mediates its effects through a seven-transmembrane G-protein-coupled receptor (FP). The aim of this study was to examine the temporal expression, signaling, and role of FP receptor in the human endometrium. Quantitative RT-PCR analysis demonstrated highest expression of FP receptor in the mid- to late-proliferative phase, compared with early-proliferative and secretory phase endometrium. In situ hybridization studies localized FP receptor mRNA expression to the epithelial cell compartment during the mid- to late-proliferative phase. Moreover, treatment of endometrial tissue with 1–100 nM PGF2{alpha} induced a concentration-dependent increase in inositol phosphate mobilization, indicating functional FP receptor expression. The Ishikawa human endometrial epithelial cell line was used to investigate further the signaling and role of PGF2{alpha} in endometrial epithelial cells. Ishikawa cells endogenously express the FP receptor, and treatment with 1–100 nM PGF2{alpha} elicits a concentration-dependent increase in inositol phosphate release. Moreover, treatment of Ishikawa cells with 100 nM PGF2{alpha} induced phosphorylation of ERK1/2 that was abolished when cells were cotreated with 50 µM PD98059 (MAPK kinase inhibitor) or 10 µM U73122 [phospholipase C (PLC) inhibitor]. Treatment of Ishikawa cells with PGF2{alpha} for 24 h induced a significant concentration-dependent increase in Ishikawa cell proliferation. Coincubation of the cells with 50 µM PD98059 or 2 µM U73122 demonstrated that PLC inhibition significantly reduced PGF2{alpha}-induced proliferation, whereas MAPK kinase inhibition had no effect. In summary, these studies demonstrate increased FP receptor expression in endometrial epithelial cells during the proliferative phase of the menstrual cycle and identify a role for PGF2{alpha} in epithelial cell proliferation via a PLC-dependent pathway.

Abbreviations: COX, Cyclooxygenase; DMSO, dimethylsulfoxide; FITC, fluorescein isothiocyanate; FP, PGF2{alpha} receptor; GPCR, G-protein-coupled receptor; ISH, in situ hybridization; MEK, MAPK kinase; PG, prostaglandin; PLC, phospholipase C; RT, reverse transcription.




This article has been cited by other articles:


Home page
EndocrinologyHome page
K. J. Sales, S. C. Boddy, A. R. W. Williams, R. A. Anderson, and H. N. Jabbour
F-Prostanoid Receptor Regulation of Fibroblast Growth Factor 2 Signaling in Endometrial Adenocarcinoma Cells
Endocrinology, August 1, 2007; 148(8): 3635 - 3644.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
H. Achache and A. Revel
Endometrial receptivity markers, the journey to successful embryo implantation
Hum. Reprod. Update, November 1, 2006; 12(6): 731 - 746.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. P. Milling Smith, S. Battersby, K. J. Sales, H. O. D. Critchley, and H. N. Jabbour
Prostacyclin Receptor Up-Regulates the Expression of Angiogenic Genes in Human Endometrium via Cross Talk with Epidermal Growth Factor Receptor and the Extracellular Signaling Receptor Kinase 1/2 Pathway
Endocrinology, April 1, 2006; 147(4): 1697 - 1705.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. N. Jabbour, R. W. Kelly, H. M. Fraser, and H. O. D. Critchley
Endocrine Regulation of Menstruation
Endocr. Rev., February 1, 2006; 27(1): 17 - 46.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Husain, F. Jafri, and C. E. Crosson
Acute Effects of PGF2{alpha} on MMP-2 Secretion from Human Ciliary Muscle Cells: A PKC- and ERK-Dependent Process
Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1706 - 1713.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Kang, P. Chapdelaine, J. Parent, E. Madore, P. Y. Laberge, and M. A. Fortier
Expression of Human Prostaglandin Transporter in the Human Endometrium across the Menstrual Cycle
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2308 - 2313.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.L. Hull, A. Prentice, D.Y. Wang, R.P. Butt, S.C. Phillips, S.K. Smith, and D.S. Charnock-Jones
Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis
Hum. Reprod., February 1, 2005; 20(2): 350 - 358.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Kang, A. Akoum, P. Chapdelaine, P. Laberge, P. E. Poubelle, and M. A. Fortier
Independent regulation of prostaglandins and monocyte chemoattractant protein-1 by interleukin-1{beta} and hCG in human endometrial cells
Hum. Reprod., November 1, 2004; 19(11): 2465 - 2473.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. J. Sales, S. A. Milne, A. R. W. Williams, R. A. Anderson, and H. N. Jabbour
Expression, Localization, and Signaling of Prostaglandin F2{alpha} Receptor in Human Endometrial Adenocarcinoma: Regulation of Proliferation by Activation of the Epidermal Growth Factor Receptor and Mitogen-Activated Protein Kinase Signaling Pathways
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 986 - 993.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S Battersby, H O D Critchley, A J de Brum-Fernandes, and H N Jabbour
Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle
Reproduction, January 1, 2004; 127(1): 79 - 86.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. N. Jabbour and S. C. Boddy
Prostaglandin E2 Induces Proliferation of Glandular Epithelial Cells of the Human Endometrium via Extracellular Regulated Kinase 1/2-Mediated Pathway
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4481 - 4487.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society